Chemo drug in short supply, could take weeks

Pfizer Australia – one of three suppliers of the generic drug – said it had been overwhelmed by demand and was “working with hospitals to manage urgent patient supply”.

“We have experienced a sharp increase in demand for doxorubicin hydrochloride injection as a result of sudden stock shortages with other suppliers to the Australian market,” a Pfizer spokesperson said.

“Unfortunately, this has meant Pfizer stocks of this medicine are now in short supply. 

“We have alerted regulatory authorities while we await the urgent arrival of additional stock, which we anticipate will occur in March.”

Hospira and Sandoz also supply the drug into Australia.

A TGA spokesperson said talks were underway in a bid to secure additional supplies which “should meet any short-term shortage”.

The US FDA’s list of current drug shortages notes international supply of